Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. and its senior executives for securities fraud following a significant stock drop attributed to potential violations of federal securities laws [1][3]. Company Overview - Ardent Health operates acute care hospitals and other healthcare facilities, with a focus on the collection of accounts receivable [4]. Allegations of Fraud - The lawsuit claims that Ardent Health misrepresented its process for determining the collectability of accounts receivable, stating it relied on "detailed reviews of historical collections," while in reality, it used a "180-day cliff" method that inflated reported accounts receivable and delayed loss recognition [4]. Stock Performance Impact - On November 12, 2025, Ardent Health disclosed a $43 million revenue decrease for the quarter and a $54 million increase in professional liability reserves, leading to a stock price drop of $4.75 per share, or over 33%, from $14.05 to $9.30 on November 13, 2025 [5]. Legal Proceedings - Investors have until March 9, 2026, to request to lead the case in the U.S. District Court for the Middle District of Tennessee, with the case titled Postiwala v. Ardent Health, Inc., et al., No. 3:26-cv-00022 [3]. Law Firm Background - Bleichmar Fonti & Auld LLP, the law firm representing the plaintiffs, is recognized for its success in securities class actions and has recovered significant amounts for clients in past cases [7].
ARDENT HEALTH CLASS ACTION: Ardent Health, Inc. (ARDT) Accused of Misrepresentations About Its Revenue in Securities Lawsuit, Contact BFA Law by March 9